Sheel Biotech Limited (NSE:SHEEL)

Sheel Biotech Statistics

Total Valuation

Sheel Biotech has a market cap or net worth of INR 866.00 million. The enterprise value is 933.96 million.

Market Cap	866.00M
Enterprise Value	933.96M

Important Dates

The last earnings date was Thursday, May 28, 2026.

Earnings Date	May 28, 2026
Ex-Dividend Date	n/a

Share Statistics

Sheel Biotech has 20.35 million shares outstanding. The number of shares has increased by 19.13% in one year.

Current Share Class	20.35M
Shares Outstanding	20.35M
Shares Change (YoY)	+19.13%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	63.65%
Owned by Institutions (%)	n/a
Float	5.68M

Valuation Ratios

The trailing PE ratio is 6.36.

PE Ratio	6.36
Forward PE	n/a
PS Ratio	0.78
PB Ratio	0.68
P/TBV Ratio	0.68
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.50, with an EV/FCF ratio of -3.85.

EV / Earnings	7.94
EV / Sales	0.84
EV / EBITDA	5.50
EV / EBIT	5.86
EV / FCF	-3.85

Financial Position

The company has a current ratio of 7.53, with a Debt / Equity ratio of 0.07.

Current Ratio	7.53
Quick Ratio	3.77
Debt / Equity	0.07
Debt / EBITDA	0.53
Debt / FCF	-0.37
Interest Coverage	8.32

Financial Efficiency

Return on equity (ROE) is 11.15% and return on invested capital (ROIC) is 9.99%.

Return on Equity (ROE)	11.15%
Return on Assets (ROA)	7.69%
Return on Invested Capital (ROIC)	9.99%
Return on Capital Employed (ROCE)	12.37%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.85
Inventory Turnover	1.97

Taxes

In the past 12 months, Sheel Biotech has paid 22.60 million in taxes.

Income Tax	22.60M
Effective Tax Rate	16.12%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	45.27
200-Day Moving Average	n/a
Relative Strength Index (RSI)	50.27
Average Volume (20 Days)	8,200

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sheel Biotech had revenue of INR 1.11 billion and earned 117.56 million in profits. Earnings per share was 6.69.

Revenue	1.11B
Gross Profit	427.85M
Operating Income	159.30M
Pretax Income	140.16M
Net Income	117.56M
EBITDA	169.96M
EBIT	159.30M
Earnings Per Share (EPS)	6.69

Balance Sheet

The company has 21.83 million in cash and 89.79 million in debt, with a net cash position of -67.96 million or -3.34 per share.

Cash & Cash Equivalents	21.83M
Total Debt	89.79M
Net Cash	-67.96M
Net Cash Per Share	-3.34
Equity (Book Value)	1.27B
Book Value Per Share	61.51
Working Capital	1.11B

Cash Flow

In the last 12 months, operating cash flow was -175.69 million and capital expenditures -66.60 million, giving a free cash flow of -242.28 million.

Operating Cash Flow	-175.69M
Capital Expenditures	-66.60M
Depreciation & Amortization	10.66M
Net Borrowing	-35.79M
Free Cash Flow	-242.28M
FCF Per Share	-11.90

Margins

Gross margin is 38.64%, with operating and profit margins of 14.39% and 10.62%.

Gross Margin	38.64%
Operating Margin	14.39%
Pretax Margin	12.66%
Profit Margin	10.62%
EBITDA Margin	15.35%
EBIT Margin	14.39%
FCF Margin	n/a

Dividends & Yields

Sheel Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-19.13%
Shareholder Yield	-19.13%
Earnings Yield	13.58%
FCF Yield	-27.98%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5